Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04335734
Other study ID # ONMedU 1
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 1, 2012
Est. completion date May 28, 2019

Study information

Verified date April 2020
Source Odessa National Medical University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Patients who underwent anti-reflux surgery were divided into two groups. In the I group Nissen fundoplication was supplemented with suturing wrap to the crura or the body of stomach using two non-absorbable stitches on each side. Control group included patients who underwent classic Nissen fundoplication without wrap fixation. All patients were assessed before and after surgery using validated symptoms and quality of life (GERD-HRQL) questionnaires, 24-h impedance-pH monitoring and barium-swallow.


Recruitment information / eligibility

Status Completed
Enrollment 138
Est. completion date May 28, 2019
Est. primary completion date October 1, 2014
Accepts healthy volunteers No
Gender All
Age group 20 Years to 80 Years
Eligibility Inclusion Criteria:

- Age: 20 - 80 years;

- Gastroesophageal reflux disease as evidence by gastroscopy and pH-monitoring;

- HH type I, II

Exclusion Criteria:

- Age < 20 years and > 80 years;

- Unable to undergo laparoscopic fundoplication due to: severe comorbidities (ASA III and more), previous major surgery with severe adhesions, etc.;

- HH type III, IV;

- BMI < 16 and > 45 kg/m²;

- Pregnancy (in females);

- Oesophageal motility disorders;

- Oesophageal peptic strictures;

- Oesophageal diverticula, other types (i.e. non-reflux) of chronic esophagitis, connective tissue disorders (e.g. scleroderma);

- History of oesophageal/gastric/duodenal surgery including vagotomy;

- Relapsing course of ulcer disease/hyperacid gastritis including complicated by delayed gastric/duodenal emptying

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Nissen Fundoplication with wrap fixation
Firstly, we performed left crural dissection, division of the short gastric vessels, right crural dissection, and esophageal mobilization. Then repair of HH were made by simple cruroraphy if the size of the defect was less then 10 ?m² otherwise mesh for reinforcement of cruroraphy was used. Creation of the wrap was made by passing posterior fundus behind the esophagus from left to right, followed by stitching the edges of the stomach with three interrupted sutures. Wrap was fixated to both diaphragmatic crura or to the body of stomach using two non-absorbable stitches on each side.
Nissen Fundoplication without wrap fixation
Firstly, we performed left crural dissection, division of the short gastric vessels, right crural dissection, and esophageal mobilization. Then repair of HH were made by simple cruroraphy if the size of the defect was less then 10 ?m² otherwise mesh for reinforcement of cruroraphy was used. Creation of the wrap was made by passing posterior fundus behind the esophagus from left to right, followed by stitching the edges of the stomach with three interrupted sutures.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Grubnik Volodymyr

Outcome

Type Measure Description Time frame Safety issue
Primary Recurrence rate of hiatal hernia Recurrence of hiatal hernia will be assessed by barium contrast swallow study 60 months
Primary Slipped wrap Slipped wrap will be assessed by barium contrast swallow study 60 months
Secondary Quality of life and satisfaction Quality of life and satisfaction will be assessed by Gastroesophageal reflux disease - health-related quality of life (GERD-HRQL) score. The scale has 11 items,each item is scored from 0 to 5. A higher score indicating a better quality of life. 60 months
See also
  Status Clinical Trial Phase
Completed NCT01710995 - A Three-Period Study to Investigate the Relative Bioavailability and Pharmacodynamic Profiles of a Zegerid 20mg Capsule, Zegerid 20mg Powder for Oral Suspension and Losec 20mg Capsule in Healthy Adult Volunteers Under Fasting Conditions Phase 1
Completed NCT05129670 - Clinical Investigation to Assess the Acid Neutralisation Activity of a Calcite Chewing Gum N/A